Beyond Air announces sale of 85% of NeuroNOS to XTL Biopharmaceuticals, gaining cash, shares, and milestones, as XAIR stock jumps 165% premarket.
Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future Payments
Beyond Air announces sale of 85% of NeuroNOS to XTL Biopharmaceuticals, gaining cash, shares, and milestones, as XAIR stock jumps 165% premarket.
